Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
U.S. Gun Violence Rates Jumped 30% During PandemicMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyU.S. Has Shared 200 Million Shots With Other CountriesLittle Change Seen in Americans' Use of Mental Health Services During PandemicWomen Doctors Face Higher Levels of Harassment, Frustration: SurveyEPA Plans New Strategy Against PFAS 'Forever Chemicals'State Spending on Poverty Really Pays Off for Kids: StudyState Lotteries Didn't Help Boost Vaccination RatesVaccinated Foreign Travelers Can Enter United States Beginning Nov. 8Despite Pressures of Pandemic, U.S. Nursing School Enrollment ClimbsBiden Administration to Invest $100 Million to Ease Health Worker ShortageFDA Warns Against Using At-Home Dermal Filler 'Pens'Death Threats, Trolling Common for Scientists Who Speak to Media About COVID'Extreme Heat' Days Have Tripled Since 1980s, and More Are ComingAHA News: Are Monolingual Spanish Speakers More at Risk in the Pandemic?Your Free Cancer Screen Shows Trouble: What If You Can't Afford the Follow-Up?Bystanders Can Make the Difference for a Drowning ChildClimate Change is World's Most Pressing Health Problem: WHOAHA News: Another Barrier for Black and Hispanic People: Good Mental Health CareU.S. to Buy $1 Billion Worth of Rapid COVID TestsNearly 200,000 COVID Home Tests Recalled Over False PositivesMedical Mistrust Fuels Vaccine Hesitancy Among HispanicsAmericans Divided on Biden's Vaccine Mandate, Poll FindsAir Pollution Linked to 6 Million Premature Births in 1 YearDelay in Graphic Warning Labels on Cigarettes Cost Lives: StudyAHA News: Women May Be More Willing Than Men to Donate OrgansEPA to Sharply Limit Refrigerant Production in New Climate RuleAHA News: Food Insecurity's Long-Term Health ConsequencesU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationNIH Spending Nearly $470 Million on Long-Haul COVID StudyCOVAX Cuts Global COVID Vaccine Supply Estimates By a QuarterFDA Bans Sale of Nearly a Million E-Cigarettes; Allows Juul to Remain on MarketMore Affordable Housing, Healthier Hearts?Biden to Strengthen Push for Vaccine Mandates in New COVID PlanU.S. COVID Vaccination Rates Climb in AugustGreener Neighborhoods Bring Healthier Hearts, Study ShowsU.S. to Be Removed From E.U. Safe Travel ListFDA Tells Three Small E-Cigarette Makers to Stop Selling Flavored ProductsFratelli Beretta Antipasto Trays Are the Source of Salmonella Outbreak: CDCHow Your Medicines Make Their Way Into Rivers, Lakes and BaysFamily Behind Oxycontin Denies Any Responsibility for Opioid CrisisCommon Pesticide to Be Banned Over Links to  Problems in ChildrenFar Too Few People of Color in U.S. Pancreatic Cancer TrialsRace-Based Disparities in Americans' Health Haven't Improved: StudyChild Injuries, Deaths Spur Recall of 10 Million Magnet Balls, CubesAmericans Have High Trust in Health Care Providers: PollBreaded, Raw Chicken Recalled in Multi-State Salmonella OutbreakU.S. Military Members Must Get COVID Vaccine by Mid-September6 Tips on Getting Back to Your Regular Doctor's CheckupNursing Home Staff Closest to Patients Are Least Likely to Get COVID Vaccines
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Far Too Few People of Color in U.S. Pancreatic Cancer Trials

HealthDay News
by Robert Preidt
Updated: Aug 18th 2021

new article illustration

WEDNESDAY, Aug. 18, 2021 (HealthDay News) -- Racial and ethnic minorities in the United States are severely underrepresented in clinical trials testing cutting-edge treatments for pancreatic cancer, researchers say.

"There are a ton of obstacles to get these patients into clinical trials," said senior author Dr. Jose Trevino, chairman of surgical oncology at Virginia Commonwealth University School of Medicine. "But this is how we're going to understand the disease better. And it's critically important for the future of cancer health disparities."

His team's analysis of the clinicaltrials.gov database revealed that 207 trials for pancreatic cancer treatments were conducted in the United States between 2005 and last year. They had a combined total of more than 8,400 participants.

Eight percent were Black participants, even though 12% of pancreatic cancer cases occur among Black patients. Similarly, Hispanic patients made up 6% of trial participants and 9% of cases. Asian patients represented 2% of trial participants and 3% of cases, while Native and Indigenous Americans were 0.3% of trial participants and 0.4% of cases.

Several factors contribute to the lack of diversity in the treatment trials, according to the authors of the study, published Aug. 17 in the journal Gastroenterology.

They include mistrust of the medical establishment; bias among health care providers; strict clinical trial inclusion criteria, and lack of diversity among the clinicians who are recruiting patients to trials.

The authors offered several suggestions to narrow the gaps. Among them: not automatically excluding people with high blood pressure, diabetes and HIV, if their symptoms are well controlled. These chronic diseases are more common in Black, Hispanic and Native and Indigenous Americans.

The authors said the lack of diversity in pancreatic treatment clinical trials not only harms patients in minority groups but also impedes efforts to fight the deadly disease.

"If we don't have diversity in clinical trials, how will we ever know whether we have certain drugs that work better in some populations than others?" Trevino said in a university news release. "We could be throwing away a really good treatment option for racial and ethnic minority patients."

More information

The American Cancer Society has more on pancreatic cancer.

SOURCE: Virginia Commonwealth University, news release, Aug. 17, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net